Max Robotics — Global Service Robot Directory + US Certification

About

Rolf Eigil Berg is a leading urologic surgeon and researcher whose work focuses on improving outcomes for prostate cancer patients through advanced surgical techniques and imaging. His major contributions center on the transition from laparoscopic to robot-assisted radical prostatectomy, where his prospective studies have demonstrated that robotic approaches can maintain oncological control while potentially improving quality of life and reducing complications. Berg’s landmark 2015 randomized clinical trial, cited 69 times, critically evaluated whether preoperative MRI reduces positive surgical margins—a question with direct implications for surgical planning and patient prognosis. He has also pioneered comparative effectiveness research, showing that switching from laparoscopic to robotic surgery yields comparable oncological outcomes with fewer adverse events. More recently, Berg has ventured into focal ablation as a less invasive alternative to radical prostatectomy for intermediate-risk disease, with an ongoing randomized controlled trial that could reshape treatment paradigms. His work, consistently published in top urology journals, has earned over 135 citations and positions him as a key figure in the evidence-based evolution of prostate cancer surgery.